How Can Medication Adherence be Improved?

Raulo Frear, PharmD, general manager of OmedaRx, discusses developing trends in medication compliance.

Related Videos

Related Content

FDA Approves Trofinetide for Treatment of Rett Syndrome in Adult, Pediatric Patients

March 13th 2023

Pharmacy Focus: Psychedelic Pharmacy - Understanding Natural vs. Synthetic Psychedelics

January 13th 2023

FDA Approves Omavaloxolone, the First Drug Indicated for Patients With Friedreich’s Ataxia

March 1st 2023

Pharmacy Focus: Public Health Matters- Celebrating American Pharmacist Month Part 2 with Autumn Zuckerman

October 13th 2022

New Set of Recommendations Can Help Pharmacy Practice Authors Pick Best Journal to Publish Research

February 28th 2023

AI and Pharma: Creating Improved Outcomes for Patients and Practitioners

February 27th 2023

FDA Approves Trofinetide for Treatment of Rett Syndrome in Adult, Pediatric Patients

March 13th 2023

Pharmacy Focus: Psychedelic Pharmacy - Understanding Natural vs. Synthetic Psychedelics

January 13th 2023

FDA Approves Omavaloxolone, the First Drug Indicated for Patients With Friedreich’s Ataxia

March 1st 2023

Pharmacy Focus: Public Health Matters- Celebrating American Pharmacist Month Part 2 with Autumn Zuckerman

October 13th 2022

New Set of Recommendations Can Help Pharmacy Practice Authors Pick Best Journal to Publish Research

February 28th 2023

AI and Pharma: Creating Improved Outcomes for Patients and Practitioners

February 27th 2023

FDA Approves Trofinetide for Treatment of Rett Syndrome in Adult, Pediatric Patients

March 13th 2023

Pharmacy Focus: Psychedelic Pharmacy - Understanding Natural vs. Synthetic Psychedelics

January 13th 2023

FDA Approves Omavaloxolone, the First Drug Indicated for Patients With Friedreich’s Ataxia

March 1st 2023

Pharmacy Focus: Public Health Matters- Celebrating American Pharmacist Month Part 2 with Autumn Zuckerman

October 13th 2022

New Set of Recommendations Can Help Pharmacy Practice Authors Pick Best Journal to Publish Research

February 28th 2023

AI and Pharma: Creating Improved Outcomes for Patients and Practitioners

February 27th 2023

Related Content

FDA Approves Trofinetide for Treatment of Rett Syndrome in Adult, Pediatric Patients

March 13th 2023

Article

Pharmacy Focus: Psychedelic Pharmacy - Understanding Natural vs. Synthetic Psychedelics

January 13th 2023

Podcast

FDA Approves Omavaloxolone, the First Drug Indicated for Patients With Friedreich’s Ataxia

March 1st 2023

Article

Pharmacy Focus: Public Health Matters- Celebrating American Pharmacist Month Part 2 with Autumn Zuckerman

October 13th 2022

Podcast

New Set of Recommendations Can Help Pharmacy Practice Authors Pick Best Journal to Publish Research

February 28th 2023

Article

AI and Pharma: Creating Improved Outcomes for Patients and Practitioners

February 27th 2023

Article